Table of Contents Table of Contents
Previous Page  32 / 236 Next Page
Information
Show Menu
Previous Page 32 / 236 Next Page
Page Background

candidates was undertaken in three studies.

18,21,23

Most

patients had been suffering with ENS for many years

(up to 29.7 years

12

), and there was general consensus

that ENS surgery was deferred for at least 1 year after

turbinectomy. Although all studies reported on patients

who had inferior turbinectomy, the degree of turbinate

resection (partial, total) was not consistently reported.

Surgical Technique

The most common surgical technique involved a

transnasal approach, with implant material secured

within a submucosal pocket. The amount and thickness of

implant material was arbitrarily decided based on how

much inferior turbinate reconstruction was necessary at

the time of the operation. Multiple implant sites in the

lateral nasal wall, remnant of the inferior turbinate or

septal area adjacent to the resected turbinate, were nor-

mally performed to narrow the nasal valve region. Com-

mon implant material used in the studies included

noncellular dermis (AlloDerm) and porous high-density

polyethylene (Medpor, Porex Surgical, Inc., GA). These

materials were used in 47% of cases, whereas autologous

(septal, conchal) and homologous (Tutoplast-processed cos-

tal cartilage; Tutogen Medical GmbH, Neunkirchen am

Brand, Germany) cartilage was utilized in 38% of cases.

In three cases, small aliquots (0.3–0.4 mL) of hyaluronic

acid gel (Juvederm; Allergan, Inc., CA) was injected into

the remnant of the head of inferior turbinate, and adja-

cent septum after the nasal mucosa was perforated with a

CO2 laser.

25

One study involving five patients embedded

nonporous

b

-tricalcium phosphate (SINUS UP; Kasios,

Launaguet, France) via a gingival incision within a sub-

mucoperiosteal pocket in the lateral nasal wall.

12

Clinical Outcomes

The follow-up period varied widely (range 6–48

months). Most studies reported postintervention data based

on an aggregated follow-up period, although two presented

results at 3-, 6-, and 12-month follow-up.

12,18

Of the eight

studies, seven assessed clinical efficacy with a patient-

reported outcome tool (Table II). Five studies utilized the

SNOT, totaling 103 patients. The weighted mean preopera-

tive SNOT-20 and SNOT-25 scores were 48.3 and 65.9

respectively. At the latest follow-up, these scores improved

significantly (

P

<

0.05) to 24.4 and 33.3, respectively.

Averaged scores of individual SNOT questions were

available from 64 patients, which enabled the analysis of

SNOT subdomains.

12,18,22

High SNOT scores were attrib-

uted to issues of reduced productivity, poor concentra-

tion, and feeling frustrated. Although all SNOT

subdomains improved subsequent to surgery, the largest

improvement was observed in ENS symptoms and

TABLE II.

Summary of Evaluated Studies Included in This Review in Chronological Order.

First Author

(year of publication)

Number of

Patients

Age

(years)

Gender Distribution

(male:female)

Implant

Material

Surgical

Approach

Outcome

Measures

Follow-up

(months)

Jiang (2014)

24

18–64

18:6

Medpor

Transnasal SNOT-25

3,6,12

Tam (2014)

16

31–68

10:6

Medpor

Transnasal SNOT-22

12

Jung (2013)

31 Mean 43.5

22:9

Conchal, costal

cartilage

Transnasal SNOT-25

6

Bastier (2013)

5 49.2–54.7

3:2

Nonporous

b

-tricalcium

phosphate

Transoral

NOSE,

RhinolQoL

Mean 13.5, Range 8.2–21

Saafan (2013)

24 Mean 27

11:13

12

3

AlloDerm,

12

3

Silastic

Transnasal SNOT-25

Mean 18, Range 9–24

Modrzynski (2011)

3

48–64

2:1

Hyaluronic

acid gel

Transnasal Subjective,

acoustic

rhinometry

12

Jang (2011)

17

20–66

11:6

Cartilage

(autologous,

homologous)

Transnasal 10-point visual

analogue scale

Mean 11.8, Range 6 - 27

Houser (2007)

8

18–45

7:1

AlloDerm

Transnasal SNOT-20

Range 6–48

NOSE

5

Nasal Obstruction Symptom Evaluation; RhinolQOL

5

Rhinosinusitis Quality of Life; SNOT

5

Sino-Nasal Outcome Test.

Fig. 2. Changes in average pre- and postoperative Sino-Nasal

Outcome Test subdomain scores, based on data obtained from

Jiang et al.,

17

Tam et al.,

18

Jung et al.,

19

and Saafan et al.

22

The

maximum score column represents the maximum possible score

for that particular subdomain. ENS

5

empty nose syndrome.

[Color figure can be viewed in the online issue, which is available

at

www.laryngoscope.com

.]

Laryngoscope 125: July 2015

Leong: Surgical Interventions for Empty Nose Syndrome

10